• tyc7111cc太阳成集团

    洞察市场格局
    解锁药品研发情报

    免费客服电话

    18983288589
    医药数据查询

    【ChiCTR1900028695】Recovery-oriented cognitive-behaviour approach for people with schizophrenia in Hong Kong

    基本信息
    登记号

    ChiCTR1900028695

    试验状态

    尚未开始

    药物名称

    /

    药物类型

    /

    规范名称

    /

    首次公示信息日的期

    2019-12-31

    临床申请受理号

    /

    靶点

    /

    适应症

    schizophrenia

    试验通俗题目

    Recovery-oriented cognitive-behaviour approach for people with schizophrenia in Hong Kong

    试验专业题目

    The effectiveness of a professionally-facilitated recovery-oriented cognitive-behaviour approach for people with schizophrenia in Hong Kong: A comparison to a peer-led peer support programme

    申办单位信息
    申请人联系人
    申请人名称
    联系人邮箱
    联系人邮编

    联系人通讯地址
    临床试验信息
    试验目的

    This study primarily intends to evaluate the effectiveness and differential benefits of two recovery models, namely, professionally-facilitated recovery-oriented cognitive-behaviour approach (ROCBA) and a peer-led peer support programme (PSP), which have shown initial promising results for Chinese people with schizophrenia in Hong Kong.

    试验分类
    试验类型

    随机平行对照

    试验分期

    探索性研究/预试验

    随机化

    A research assistant who is blind to the research design will generate the random number sequence for randomization. A series of block sequence following mixed block sizes (the lock size can be three and six) to assign sample numbers equally to each group. And then randomize the possible sequences block

    盲法

    Open label

    试验项目经费来源

    General Research Fund (GRF) of the University Grants Committee of the HKSAR

    试验范围

    /

    目标入组人数

    50

    实际入组人数

    /

    第一例入组时间

    2020-01-01

    试验终止时间

    2020-12-31

    是否属于一致性

    /

    入选标准

    (1) Chinese adults aged 18 to 65 years; (2) able to understand Cantonese or Chinese; (3) have a diagnosis of DSM-V schizophrenia or schizophrenia spectrum disorders; (4) currently experiencing a low level of functioning above 10 as indicated by SFQ scores, and (5) compliant to medications.；

    排除标准

    Exclusion criteria include neurological disease or damage that would compromise cognitive functioning, physical handicaps that would interfere with assessment procedures or therapy attendance, and/or suicidal attempts or ideation in the past three months.；

    研究者信息
    研究负责人姓名
    试验机构

    香港大學

    研究负责人电话
    研究负责人邮箱
    研究负责人邮编

    /

    联系人通讯地址

    香港大學的其他临床试验

    更多

    最新临床资讯

    tyc7111cc太阳成集团企业版
    50亿+条医药数据随时查
    7天免费试用
    体验产品